News &amp; Updates

Use of cannabis among Singaporeans usually starts during teenage years, primarily because of peer influence, reveals a study. Later in life, these users may progress to other illicit drugs such as heroin.

Cannabis use in SG often begins during adolescence

$Paroxetine safe, effective for refractory erythema of rosacea$

Paroxetine safe, effective for refractory erythema of rosacea

Treatment with paroxetine is effective against moderate-to-severe erythema of rosacea and has no serious adverse effects, a study has shown.

Paroxetine safe, effective for refractory erythema of rosacea

21 Jun 2023

Novel drug STRIDES in the right direction for knee OA

In the phase III STRIDES X-Ray Extension study, additional doses of the investigational CLK/DYRK inhibitor lorecivivint delivered favourable outcomes for individuals with advanced knee osteoarthritis (OA).

Novel drug STRIDES in the right direction for knee OA

21 Jun 2023

COVID-19 oral antivirals reduce hospitalization and inpatient progression in nursing home residents

A territory-wide, retrospective cohort study in Hong Kong has shown that molnupiravir and nirmatrelvir/ritonavir are effective in reducing the risks of hospitalization and inpatient disease progression among older patients residing in nursing homes.

COVID-19 oral antivirals reduce hospitalization and inpatient progression in nursing home residents

Dapagliflozin helps prevent heart failure events, cardiovascular death

Treatment with dapagliflozin leads to a reduction in the rate of total heart failure (HF) events and cardiovascular death, irrespective of patient characteristics such as ejection fraction (EF), according to data from the DELIVER* trial.

Dapagliflozin helps prevent heart failure events, cardiovascular death

Dazodalibep reduces Sjögren’s syndrome-related symptoms

Treatment with dazodalibep, a novel nonantibody fusion protein that acts as an antagonist of CD40 ligand, significantly reduced symptom burden in adults with Sjögren’s syndrome, according to the ALISS trial presented at EULAR 2023.

Dazodalibep reduces Sjögren’s syndrome-related symptoms

Romosozumab one-ups denosumab in boosting bone mineral density for chronic steroid users

20 Jun 2023 by

In the treatment of chronic glucocorticoid users with high fracture risk, romosozumab yields higher gains in spine bone mineral density (BMD) compared with denosumab, as shown in a pilot trial presented at EULAR 2023.

Romosozumab one-ups denosumab in boosting bone mineral density for chronic steroid users

Visceral adipose tissue buildup tied to lower muscle density

Age-related accumulation of visceral adipose tissue (VAT) in both men and women may result in lower paraspinal muscle density, suggests a study.

Visceral adipose tissue buildup tied to lower muscle density

AI predicts early-stage rheumatoid arthritis using MRI scans

20 Jun 2023 by

It is now possible to predict rheumatoid arthritis (RA), thanks to interpretations of magnetic resonance imaging (MRI) scans made by an artificial intelligence (AI) model.

AI predicts early-stage rheumatoid arthritis using MRI scans

20 Jun 2023

Which factors contribute to skin neoplasms in Lynch syndrome patients?

Individuals with Lynch syndrome (LS) often develop skin neoplasms, reports a recent study, which has identified several clinical factors that contribute to LS- and non-LS-related skin neoplasms.

Which factors contribute to skin neoplasms in Lynch syndrome patients?